ATP Inhibits the Transcription Factor STAT5b

被引:6
|
作者
Berg, Angela [1 ]
Sperl, Bianca [2 ]
Berg, Thorsten [1 ]
机构
[1] Univ Leipzig, Inst Organ Chem, Johannisallee 29, D-04103 Leipzig, Germany
[2] Max Planck Inst Biochem, Dept Mol Biol, Klopferspitz 18, D-82152 Martinsried, Germany
关键词
bioactive compounds; inhibitors; nucleotides; protein-protein interactions; SH2; domain; SIGNAL TRANSDUCER; SELECTIVE INHIBITORS; DISCOVERY; ACTIVATOR; CANCER; MODULATORS; DOMAINS; TARGETS; POTENT; ASSAY;
D O I
10.1002/cbic.201900173
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Although naturally occurring low-molecular-weight compounds have many known roles within the cell, these do not usually involve the direct inhibition of protein-protein interactions. Based on the results of high-throughput screening of a library of bioactive compounds and neurotransmitters, we report here that the four nucleoside triphosphates ATP, GTP, CTP and UTP inhibit the SH2 domain of the tumor-related transcription factor STAT5b. ATP and GTP are the most active nucleoside triphosphates and show specificity for STAT5b over STAT5a, STAT3, STAT6 and the p53-binding protein HDM2. As the inhibition constant of ATP against STAT5b is significantly lower than published values for the intracellular ATP concentration, our data suggest that ATP might inhibit the protein-protein interactions of STAT5b in living cells.
引用
收藏
页码:2227 / 2231
页数:5
相关论文
共 50 条
  • [1] Nanomolar Inhibitors of the Transcription Factor STAT5b with High Selectivity over STAT5a
    Elumalai, Nagarajan
    Berg, Angela
    Natarajan, Kalaiselvi
    Scharow, Andrej
    Berg, Thorsten
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2015, 54 (16) : 4758 - 4763
  • [2] Phosphorylation of Capsaicinoid Derivatives Provides Highly Potent and Selective Inhibitors of the Transcription Factor STAT5b
    Elumalai, Nagarajan
    Berg, Angela
    Rubner, Stefan
    Berg, Thorsten
    ACS CHEMICAL BIOLOGY, 2015, 10 (12) : 2884 - 2890
  • [3] Rational development of Stafib-2: a selective, nanomolar inhibitor of the transcription factor STAT5b
    Elumalai, Nagarajan
    Berg, Angela
    Rubner, Stefan
    Blechschmidt, Linda
    Song, Chen
    Natarajan, Kalaiselvi
    Matysik, Joerg
    Berg, Thorsten
    SCIENTIFIC REPORTS, 2017, 7
  • [4] Antagonizing STAT5B dimerization with an osmium complex
    Liu, Li-Juan
    Wang, Wanhe
    Kang, Tian-Shu
    Liang, Jia-Xin
    Liu, Chenfu
    Kwong, Daniel W. J.
    Wong, Vincent Kam Wai
    Ma, Dik-Lung
    Leung, Chung-Hang
    SCIENTIFIC REPORTS, 2016, 6
  • [5] Asymmetrically Substituted m-Terphenyl Phosphates Inhibit the Transcription Factor STAT5a
    Mueller-Klieser, Daniel
    Berg, Thorsten
    CHEMBIOCHEM, 2022, 23 (04)
  • [6] The Selectivity of Fosfosal for STAT5b over STAT5a is Mediated by Arg566 in the Linker Domain
    Graeb, Julian
    Berg, Thorsten
    CHEMBIOCHEM, 2020, 21 (16) : 2264 - 2267
  • [7] The STAT5b Linker Domain Mediates the Selectivity of Catechol Bisphosphates for STAT5b over STAT5a
    Graeb, Julian
    Berg, Angela
    Blechschmidt, Linda
    Kluever, Barbara
    Rubner, Stefan
    Fu, Darwin Y.
    Meiler, Jens
    Graeber, Martin
    Berg, Thorsten
    ACS CHEMICAL BIOLOGY, 2019, 14 (04) : 796 - 805
  • [8] Halogen-substituted catechol bisphosphates are potent and selective inhibitors of the transcription factor STAT5b
    Elumalai, Nagarajan
    Natarajan, Kalaiselvi
    Berg, Thorsten
    BIOORGANIC & MEDICINAL CHEMISTRY, 2017, 25 (14) : 3871 - 3882
  • [9] Biaryl Phosphates and Phosphonates as Selective Inhibitors of the Transcription Factor STAT4
    Brovchenko, Nadiya
    Berg, Angela
    Schubert, Sabine
    Graeb, Julian
    Muenzel, Theresa
    Protzel, Christoph
    Natarajan, Kalaiselvi
    Berg, Thorsten
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2025,
  • [10] STAT3, STAT5A, STAT5B and STAT6 proteins are overexpressed in human basal cell carcinoma
    Slawinska, M.
    Lakomy, J.
    Biernat, W.
    Sokolowska-Wojdylo, M.
    Karczewska, J.
    Zablotna, M.
    Jankau, J.
    Nowicki, R. J.
    Sobjanek, M.
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2020, 45 (02) : 165 - 171